Physician profile

Victor Schmelzer

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Edgewood, KY

NPI 1013973262

$2,784.75

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$245.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $1,770.77 2019-2022
Medtronic, INC. $430.28 2021-2022
Edwards Lifesciences Corporation $260.59 2020-2023 Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve
Artivion, INC. $183.28 2023 On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder
Atricure, INC. $58.30 2021
Getinge USA Sales, LLC $45.15 2021-2022
Medtronic Vascular, INC. $36.38 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Victor Schmelzer

$2,784.75

in general payments reported 2019-2025

Years
2019-2023
Top company
Abbott Laboratories

https://glasscript.com/doctor/46508/victor-schmelzer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.